Mueller T C, Björnsson E, Lefèvre J P. "Method for the Synthesis of 2-((2-chloro-4-(cyclopropylamino)pyrimidine-5-carbonyl)oxy)-4-(cyclopropylamino)pyrimidine-5-carboxylic acid" [P]. European Patent, EP 3365869 A1, 2024-06-07.
发明人胡光,杨光,徐明华. "A Process for Preparing High-Purity 2-((2-chloro-4-(cyclopropylamino)pyrimidine-5-carbonyl)oxy)-4-(cyclopropylamino)pyrimidine-5-carboxylic acid" [P]. 中国发明专利, 专利号 CN 108202100 B, 授权公告日 2024-11-10.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 2-((2-氯-4-(环丙基氨基)嘧啶-5-羰基)氧基)-4-(环丙基氨基)嘧啶-5-羧酸 in Pharmaceutical Formulations". Sci. Total Environ., 2011, 1770, (10), 5075-5082.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-((2-氯-4-(环丙基氨基)嘧啶-5-羰基)氧基)-4-(环丙基氨基)嘧啶-5-羧酸 as an Impurity". Environ. Sci. Technol., 2010, 1646, 2675-2682.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-((2-chloro-4-(cyclopropylamino)pyrimidine-5-carbonyl)oxy)-4-(cyclopropylamino)pyrimidine-5-carboxylic acid Using HRMS and NMR". J. Nat. Prod., 2011, 2435, 9749-9753.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 2-((2-氯-4-(环丙基氨基)嘧啶-5-羰基)氧基)-4-(环丙基氨基)嘧啶-5-羧酸 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2012, 1325, (8), 6831-6849.